164 related articles for article (PubMed ID: 21546206)
1. MicroRNA-21 and PDCD4 expression in colorectal cancer.
Chang KH; Miller N; Kheirelseid EA; Ingoldsby H; Hennessy E; Curran CE; Curran S; Smith MJ; Regan M; McAnena OJ; Kerin MJ
Eur J Surg Oncol; 2011 Jul; 37(7):597-603. PubMed ID: 21546206
[TBL] [Abstract][Full Text] [Related]
2. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
5. Pdcd4, a colon cancer prognostic that is regulated by a microRNA.
Allgayer H
Crit Rev Oncol Hematol; 2010 Mar; 73(3):185-91. PubMed ID: 19836969
[TBL] [Abstract][Full Text] [Related]
6. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.
Fassan M; Pizzi M; Giacomelli L; Mescoli C; Ludwig K; Pucciarelli S; Rugge M
Virchows Arch; 2011 Apr; 458(4):413-9. PubMed ID: 21279518
[TBL] [Abstract][Full Text] [Related]
7. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.
Yamamichi N; Shimomura R; Inada K; Sakurai K; Haraguchi T; Ozaki Y; Fujita S; Mizutani T; Furukawa C; Fujishiro M; Ichinose M; Shiogama K; Tsutsumi Y; Omata M; Iba H
Clin Cancer Res; 2009 Jun; 15(12):4009-16. PubMed ID: 19509156
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M
Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219
[TBL] [Abstract][Full Text] [Related]
9. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
Liu X; Zhang Z; Sun L; Chai N; Tang S; Jin J; Hu H; Nie Y; Wang X; Wu K; Jin H; Fan D
Carcinogenesis; 2011 Dec; 32(12):1798-805. PubMed ID: 21934092
[TBL] [Abstract][Full Text] [Related]
12. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
[TBL] [Abstract][Full Text] [Related]
13. Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.
Federico A; Zappavigna S; Romano M; Grieco P; Luce A; Marra M; Gravina AG; Stiuso P; D'Armiento FP; Vitale G; Tuccillo C; Novellino E; Loguercio C; Caraglia M
Eur J Clin Invest; 2014; 44(3):285-94. PubMed ID: 24372535
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Kakimoto T; Shiraishi R; Iwakiri R; Fujimoto K; Takahashi H; Hamajima H; Mizuta T; Ideguchi H; Toda S; Kitajima Y; Ozaki I; Matsuhashi S
Oncol Rep; 2011 Dec; 26(6):1385-92. PubMed ID: 21894439
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine.
Boer K; Helinger E; Helinger A; Pocza P; Pos Z; Demeter P; Baranyai Z; Dede K; Darvas Z; Falus A
Eur J Cell Biol; 2008 Apr; 87(4):227-36. PubMed ID: 18258331
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.
Shibuya H; Iinuma H; Shimada R; Horiuchi A; Watanabe T
Oncology; 2010; 79(3-4):313-20. PubMed ID: 21412018
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
[TBL] [Abstract][Full Text] [Related]
19. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia.
Oniscu A; James RM; Morris RG; Bader S; Malcomson RD; Harrison DJ
J Pathol; 2004 Aug; 203(4):909-17. PubMed ID: 15258993
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in the young patient.
Minardi AJ; Sittig KM; Zibari GB; McDonald JC
Am Surg; 1998 Sep; 64(9):849-53. PubMed ID: 9731812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
